Related Experiment Video

Updated: Jul 11, 2026

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
08:42

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research

Published on: July 31, 2017

Children and autism--Part 1--recognition and pharmacological management

Manya Angley1, Robyn Young, David Ellis

  • 1Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, and Women's and Children's Hospital, Adelaide, South Australia, Australia. manya.angley@unisa.edu.au

Australian Family Physician
|October 6, 2007
PubMed

Insights

General practitioners can help identify autism spectrum disorder (ASD) early, leading to crucial support and improved outcomes. Early intervention and careful monitoring of treatments are key for children with autism.

Area of Science:

  • Neurodevelopmental disorders
  • Pediatric medicine
  • Clinical psychology

Background:

  • Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder with varied causes and outcomes.
  • Genetic, nutritional, and environmental factors influence ASD etiology.
  • Early recognition and intervention are critical for improving developmental trajectories.

Observation:

  • General practitioners (GPs) play a vital role in recognizing potential cases of ASD.
  • Formal diagnosis facilitates timely access to essential support services.
  • Limited evidence exists regarding psychotropic medication efficacy and adverse effects in young individuals with ASD.

Findings:

  • Antipsychotic medication use in ASD populations is increasing.
  • Vigilant monitoring for adverse effects of psychotropic medications is crucial.
  • Behavioral interventions, environmental modifications, and understanding are primary management strategies.

Implications:

  • Early screening by GPs can significantly improve outcomes for children with ASD.
  • A combined approach of behavioral and pharmacological interventions may benefit children with challenging behaviors.
  • Further research is needed to establish evidence-based psychotropic treatment guidelines for ASD.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.